2,4,6-tri-tert-butylphenol

CAS732-26-3
EC211-989-5

List details

Basic info

Status Opinion Adopted
Submitter Belgium
Submitter email Reach@health.fgov.be
Regulatory programme
  • Chemical registered under REACH
ATP number and date ATP18 - (16/02/2022), 23/11/2023
Link to ATP

Classification

Proposed harmonised classification by the dossier submitter
  • Acute Tox. 4, H302
  • Skin Sens. 1B, H317
  • Repr. 2, H361d
  • STOT RE 1, H372
Hazard classes open for commenting Acute toxicity Skin corrosion/irritation Serious eye damage/eye irritation Skin sensitisation Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — single exposure Specific target organ toxicity — repeated exposure

Intention timeline

Date of intention 2018-06-05
Expected date of submission 2018-09-28
Submitted for accordance check 2018-10-01
Final submission date 2019-02-14
Start of consultation 2019-04-01
Deadline for commenting 2019-05-31
Date of opinion 2020-10-08
Legal deadline for opinion adoption 2020-08-15

Documents

CLH report
Annexes to the CLH Report
Comments received
RAC opinion
Background document

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
Jan. 18, 2023
  • ATP number and date: ATP18 - (16/02/2022), 23/11/2023
  • Link to ATP / File Title: Official Journal
  • Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
Feb. 4, 2021
  • Background document: https://echa.europa.eu/documents/10162/8d4072da-fdf0-5128-424c-3c4234a893aa
  • Comments received: https://echa.europa.eu/documents/10162/2fc925d3-d4e3-d6d4-95f1-e8784eb897b2https://echa.europa.eu/documents/10162/305c0048-21a4-e4ab-fb43-5ed5531ce11d
  • RAC opinion: https://echa.europa.eu/documents/10162/3efea59e-2eee-fe7a-4160-868cf75042ac
Dec. 14, 2020
  • Status: Opinion DevelopmentOpinion Adopted
Oct. 29, 2020
  • Date of opinion: 2020-10-08
March 16, 2020
  • Submitter email: Reach@health.fgov.be
July 5, 2019
  • Status: Public ConsultationOpinion Development
June 18, 2019
  • Comments received: https://echa.europa.eu/documents/10162/2fc925d3-d4e3-d6d4-95f1-e8784eb897b2
April 4, 2019
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/1b031443-d86b-578b-9293-dcd638a67263
  • CLH report: https://echa.europa.eu/documents/10162/4213fdf4-8a7a-9468-4c58-b5aef9cad6fe
  • Deadline for commenting: 2019-05-31
  • Final submission date: 2019-02-14
  • Hazard classes open for commenting: Acute toxicity Skin corrosion/irritation Serious eye damage/eye irritation Skin sensitisation Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — single exposure Specific target organ toxicity — repeated exposure
  • Legal deadline for opinion adoption: 2020-08-15
  • Proposed harmonised classification by the dossier submitter: Repr. 2, H361d
  • Regulatory programme: Other substanceChemical registered under REACH
  • Status: SubmittedPublic Consultation
  • Start of consultation: 2019-04-01
  • Submitter email: Reach@environment.belgium.be
Dec. 11, 2018
  • Remarks: The substance is also under substance evaluation
Oct. 23, 2018
  • Submitter: Belgium
  • Submitter email: Reach@environment.belgium.be
Oct. 16, 2018
  • Status: IntentionSubmitted
  • Submitter: Belgium
  • Submitter email: Reach@environment.belgium.be
  • Submitted for accordance check: 2018-10-01
Add the related substance to your watchlist to monitor this regulatory record.